FIELD: chemistry.
SUBSTANCE: present invention relates to use of dihydrochloride 9-diethylaminoethyl-2,3-dihydroimidzo[1,2-a]benzimidazole as a compound which inhibits erythrocyte aggregation and reduces blood viscosity, and also reduces insulin resistance and restores tolerance of the body to glucose. The invention also relates to a pharmaceutical composition based on the said dihydrochloride.
EFFECT: new potential of the of the said compound has been studied.
3 cl, 4 dwg, 9 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT SHOWING ANTIAGGREGATION ACTIVITY | 1991 |
|
RU2061481C1 |
| 2-(3,4-DIHYDROXYPHENYL)-9-DIETHYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE DIHYDROBROMIDE AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2391979C2 |
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
| 1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
| COMPOSITION POSSESSING MULTICOMPONENT MECHANISM OF ANTIDIABETIC EFFECT | 2004 |
|
RU2289419C2 |
| ANTITHROMBOTIC AGENT AFFECTING REGULATION OF THROMBOCYTE CAPACITY | 2008 |
|
RU2377990C1 |
| AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
| PHARMACEUTICAL COMPOSITION PREVENTING DEVELOPMENT OF PREEXCITATION SYNDROME | 2011 |
|
RU2453313C1 |
| AGENT POSSESSING ANTIARRHYTHMIC, ANTIFIBRILLATORY, ANTI-ISCHEMIC ACTION, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477130C1 |
| MEDICINAL SUBSTANCE FOR INHIBITION OF HELICOBACTER-LIKE EROSION-ULCEROUS INJURIES OF STOMACH MUCOSA | 2008 |
|
RU2395282C2 |
